Torrent Pharmaceuticals Limited
TORNTPHARM
Rang in Aktien
#1201
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aktienkurs
$50.31
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$19.14B
Veränderung (1 Tag)
-0.14%
Veränderung (1 Jahr)
23.83%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Torrent Pharmaceuticals Limited (TORNTPHARM)
Anzahl der ausstehenden Aktien zum June 2026: 338.45M
Laut den neuesten Finanzberichten und dem Aktienkurs von Torrent Pharmaceuticals Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 338.45M. Am Ende von March 2024 hatte das Unternehmen 338.45M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Torrent Pharmaceuticals Limited (TORNTPHARM) von 2005 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 338.45M | 0.01% |
| 2025 | 338.41M | -0.01% |
| 2024 | 338.45M | 0.00% |
| 2023 | 338.45M | 0.00% |
| 2022 | 338.45M | 0.00% |
| 2021 | 338.45M | 0.00% |
| 2020 | 338.45M | 0.00% |
| 2019 | 338.45M | 0.00% |
| 2018 | 338.45M | 0.00% |
| 2017 | 338.45M | 0.00% |
| 2016 | 338.45M | 0.00% |
| 2015 | 338.45M | 0.00% |
| 2014 | 338.45M | 0.00% |
| 2013 | 338.45M | 0.00% |
| 2012 | 338.45M | 0.00% |
| 2011 | 338.44M | 0.00% |
| 2010 | 338.44M | 0.00% |
| 2009 | 338.44M | 0.00% |
| 2008 | 338.44M | 0.00% |
| 2007 | 338.44M | 0.00% |
| 2006 | 338.44M | 0.00% |
| 2005 | 338.44M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 608.93% |
IN
|
